March 27, 2025 - 00:31

Stocks are on shifting sands as markets respond to changes in tone from Trump on coming tariffs. The Nasdaq and S&P 500 experienced significant declines, breaking their three-day winning streak amid growing concerns over potential auto tariffs. Investors are closely monitoring the situation, as the prospect of new tariffs could have far-reaching implications for various sectors, particularly the automotive industry.
Market analysts suggest that uncertainty surrounding trade policies is contributing to the volatility. As discussions around tariffs escalate, many traders are reassessing their positions, leading to a wave of selling. The impact of these tariffs could ripple through the economy, affecting supply chains and consumer prices.
In light of these developments, investors are urged to stay informed and consider the broader economic implications of the proposed tariffs. With the market reacting swiftly to news, it remains crucial for stakeholders to navigate this shifting landscape with caution.
September 12, 2026 - 00:50
US Tariff Refunds Slow as Government Collects More Than It Pays OutThe flow of tariff refunds from the US government has slowed sharply, with new figures showing the Treasury took in more money from tariffs than it returned to importers for the first time in...
September 11, 2026 - 02:46
Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another StoryRayonier Advanced Materials reported second-quarter results on August 4 for the period ending June 27, showing a mixed picture of financial performance. Net sales reached $376 million, an 18...
September 10, 2026 - 21:54
OpenAI Rolls Out ChatGPT for Financial Services With Major Industry PartnersOpenAI has introduced a version of ChatGPT built specifically for the financial sector, teaming up with several large brokerages and research organizations, including Morgan Stanley and S&P. The...
September 10, 2026 - 04:58
InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate UpdateVancouver-based InMed Pharmaceuticals has released its financial results for the full fiscal year that ended on June 30, 2026, alongside a broader update on its corporate activities. The company,...